A citation-based method for searching scientific literature


List of co-cited articles
233 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Lace M Riggs, Jaclyn N Highland, Polymnia Georgiou, Edna F R Pereira, Edson X Albuquerque, Craig J Thomas, Carlos A Zarate,[...]. Pharmacol Rev 2018
408
47

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
47

Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder.
Wallace C Duncan, Simone Sarasso, Fabio Ferrarelli, Jessica Selter, Brady A Riedner, Nadia S Hejazi, Peixiong Yuan, Nancy Brutsche, Husseini K Manji, Giulio Tononi,[...]. Int J Neuropsychopharmacol 2013
134
41

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
35

Cortical Excitability and Activation of TrkB Signaling During Rebound Slow Oscillations Are Critical for Rapid Antidepressant Responses.
Samuel Kohtala, Wiebke Theilmann, Marko Rosenholm, Leena Penna, Gulsum Karabulut, Salla Uusitalo, Kaija Järventausta, Arvi Yli-Hankala, Ipek Yalcin, Nobuaki Matsui,[...]. Mol Neurobiol 2019
22
35

The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects.
Chadi G Abdallah, Henk M De Feyter, Lynnette A Averill, Lihong Jiang, Christopher L Averill, Golam M I Chowdhury, Prerana Purohit, Robin A de Graaf, Irina Esterlis, Christoph Juchem,[...]. Neuropsychopharmacology 2018
94
35

Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder.
Wallace C Duncan, Jessica Selter, Nancy Brutsche, Simone Sarasso, Carlos A Zarate. J Affect Disord 2013
54
35

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
35

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
35

Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.
R N Moda-Sava, M H Murdock, P K Parekh, R N Fetcho, B S Huang, T N Huynh, J Witztum, D C Shaver, D L Rosenthal, E J Alway,[...]. Science 2019
243
35

Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.
Rong-Jian Liu, Francis S Lee, Xiao-Yuan Li, Francis Bambico, Ronald S Duman, George K Aghajanian. Biol Psychiatry 2012
273
29

The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome.
H A Sackeim, B Luber, G P Katzman, J R Moeller, J Prudic, D P Devanand, M S Nobler. Arch Gen Psychiatry 1996
132
29

Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects.
Allison C Nugent, Elizabeth D Ballard, Todd D Gould, Lawrence T Park, Ruin Moaddel, Nancy E Brutsche, Carlos A Zarate. Mol Psychiatry 2019
102
29



NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
860
29

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
742
29

Neurotrophin regulation of neural circuit development and function.
Hyungju Park, Mu-ming Poo. Nat Rev Neurosci 2013
23

Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial.
Peter Nagele, Andreas Duma, Michael Kopec, Marie Anne Gebara, Alireza Parsoei, Marie Walker, Alvin Janski, Vassilis N Panagopoulos, Pilar Cristancho, J Philip Miller,[...]. Biol Psychiatry 2015
104
23

Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.
Brian R Cornwell, Giacomo Salvadore, Maura Furey, Craig A Marquardt, Nancy E Brutsche, Christian Grillon, Carlos A Zarate. Biol Psychiatry 2012
110
23

The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
Cheng-Ta Li, Mu-Hong Chen, Wei-Chen Lin, Chen-Jee Hong, Bang-Hung Yang, Ren-Shyan Liu, Pei-Chi Tu, Tung-Ping Su. Hum Brain Mapp 2016
74
23

A Circadian Genomic Signature Common to Ketamine and Sleep Deprivation in the Anterior Cingulate Cortex.
Ricardo Orozco-Solis, Emilie Montellier, Lorena Aguilar-Arnal, Shogo Sato, Marquis P Vawter, Blynn G Bunney, William E Bunney, Paolo Sassone-Corsi. Biol Psychiatry 2017
59
23

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?
Wallace C Duncan, Elizabeth E Slonena, Nadia S Hejazi, Nancy Brutsche, Lawrence T Park, Ioline D Henter, Elizabeth D Ballard, Carlos A Zarate. Neuropsychiatr Dis Treat 2018
10
40

Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties.
Wallace C Duncan, Elizabeth Slonena, Nadia S Hejazi, Nancy Brutsche, Kevin C Yu, Lawrence Park, Elizabeth D Ballard, Carlos A Zarate. Biol Psychiatry 2017
46
23

Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study.
Allison C Nugent, Kathleen E Wills, Jessica R Gilbert, Carlos A Zarate. Psychiatry Res Neuroimaging 2019
21
23

Sleep and synaptic homeostasis: a hypothesis.
Giulio Tononi, Chiara Cirelli. Brain Res Bull 2003
673
23

Ketamine Treatment and Global Brain Connectivity in Major Depression.
Chadi G Abdallah, Lynnette A Averill, Katherine A Collins, Paul Geha, Jaclyn Schwartz, Christopher Averill, Kaitlin E DeWilde, Edmund Wong, Alan Anticevic, Cheuk Y Tang,[...]. Neuropsychopharmacology 2017
152
23

Ketamine-induced regulation of TrkB-GSK3β signaling is accompanied by slow EEG oscillations and sedation but is independent of hydroxynorketamine metabolites.
Samuel Kohtala, Wiebke Theilmann, Marko Rosenholm, Heidi K Müller, Paula Kiuru, Gregers Wegener, Jari Yli-Kauhaluoma, Tomi Rantamäki. Neuropharmacology 2019
13
30

Sleep recalibrates homeostatic and associative synaptic plasticity in the human cortex.
Marion Kuhn, Elias Wolf, Jonathan G Maier, Florian Mainberger, Bernd Feige, Hanna Schmid, Jan Bürklin, Sarah Maywald, Volker Mall, Nikolai H Jung,[...]. Nat Commun 2016
79
23

The use of ketamine as an antidepressant: a systematic review and meta-analysis.
Caoimhe M Coyle, Keith R Laws. Hum Psychopharmacol 2015
159
23

Circadian regulation of human cortical excitability.
Julien Q M Ly, Giulia Gaggioni, Sarah L Chellappa, Soterios Papachilleos, Alexandre Brzozowski, Chloé Borsu, Mario Rosanova, Simone Sarasso, Benita Middleton, André Luxen,[...]. Nat Commun 2016
88
23

Ketamine: A Paradigm Shift for Depression Research and Treatment.
John H Krystal, Chadi G Abdallah, Gerard Sanacora, Dennis S Charney, Ronald S Duman. Neuron 2019
154
23

Isoflurane produces antidepressant effects and induces TrkB signaling in rodents.
Hanna Antila, Maria Ryazantseva, Dina Popova, Pia Sipilä, Ramon Guirado, Samuel Kohtala, Ipek Yalcin, Jesse Lindholm, Liisa Vesa, Vinicius Sato,[...]. Sci Rep 2017
42
17


Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain.
Tomi Rantamäki, Panu Hendolin, Aino Kankaanpää, Jelena Mijatovic, Petteri Piepponen, Enrico Domenici, Moses V Chao, Pekka T Männistö, Eero Castrén. Neuropsychopharmacology 2007
219
17


Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects.
Tarique D Perera, Bruce Luber, Mitchell S Nobler, Joan Prudic, Christopher Anderson, Harold A Sackeim. Neuropsychopharmacology 2004
104
17


Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.
Jessica L Reed, Allison C Nugent, Maura L Furey, Joanna E Szczepanik, Jennifer W Evans, Carlos A Zarate. Biol Psychiatry Cogn Neurosci Neuroimaging 2019
20
17

Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action.
Joanna Ficek, Magdalena Zygmunt, Marcin Piechota, Dzesika Hoinkis, Jan Rodriguez Parkitna, Ryszard Przewlocki, Michal Korostynski. BMC Genomics 2016
24
17

Antidepressant effects of selective slow wave sleep deprivation in major depression: a high-density EEG investigation.
Eric C Landsness, Michael R Goldstein, Michael J Peterson, Giulio Tononi, Ruth M Benca. J Psychiatr Res 2011
76
17


Ketamine for depression: where do we go from here?
Marije Aan Het Rot, Carlos A Zarate, Dennis S Charney, Sanjay J Mathew. Biol Psychiatry 2012
253
17


Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
Nanxin Li, Rong-Jian Liu, Jason M Dwyer, Mounira Banasr, Boyoung Lee, Hyeon Son, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Biol Psychiatry 2011
746
17

TMS-induced cortical potentiation during wakefulness locally increases slow wave activity during sleep.
Reto Huber, Steve K Esser, Fabio Ferrarelli, Marcello Massimini, Michael J Peterson, Giulio Tononi. PLoS One 2007
164
17

Homer1a drives homeostatic scaling-down of excitatory synapses during sleep.
Graham H Diering, Raja S Nirujogi, Richard H Roth, Paul F Worley, Akhilesh Pandey, Richard L Huganir. Science 2017
255
17

Sleep, insomnia, and depression.
Dieter Riemann, Lukas B Krone, Katharina Wulff, Christoph Nissen. Neuropsychopharmacology 2020
135
17


Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.
Chadi G Abdallah, Lynnette A Averill, Ralitza Gueorguieva, Selin Goktas, Prerana Purohit, Mohini Ranganathan, Mohamed Sherif, Kyung-Heup Ahn, Deepak Cyril D'Souza, Richard Formica,[...]. Neuropsychopharmacology 2020
68
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.